Show simple item record

dc.contributor.authorParker, Jayme
dc.date.accessioned2019-10-16T21:08:57Z
dc.date.available2019-10-16T21:08:57Z
dc.date.issued2019-08
dc.identifier.urihttp://hdl.handle.net/11122/10636
dc.descriptionThesis (Ph.D.) University of Alaska Fairbanks, 2019en_US
dc.description.abstractNew technology is challenging conventional methods for characterizing pathogenic viruses in clinical laboratories. These newer methods are superior to older methods due to their ability to broadly target numerous pathogens in multiplexed ways. Even more intriguing, new technologies are capable of detecting viruses in non-targeted manners. Before these newer methods can be adopted by accredited medical laboratories, they must be validated to assess whether or not they meet minimum federal standards in terms of assay accuracy, precision, reproducibility, and cross-reactivity. This thesis begins to answer important questions facing clinical laboratories when adopting new technology. In Chapter 1, assays targeting single virus types are compared to a multiplexed assay using a proprietary electrochemical detection technology to determine if multiplexing has a detrimental effect on analytical sensitivity when detecting respiratory viruses simultaneously. Chapter 2 focuses on the issue of false positivity when testing for viruses in low-prevalence populations. To evaluate this, a multiplex flow immunoassay technology is used to perform surveillance of human immunodeficiency virus (HIV) infection in Alaskans, a low HIV-prevalence population. Chapter 3 describes clinical diagnostic applications of next-generation sequencing (NGS) providing examples of how NGS compares to conventional methods for characterizing pathogenic viruses such as hepatitis C virus, herpesvirus, adenovirus, and influenza virus. The final chapter describes how NGS can be used to characterize viruses by geographical region of transmission by analyzing an outbreak of canine parvovirus that occurred in the interior of Alaska. This chapter serves as a clear example of NGS's appeal to enhancing our epidemiological understanding during outbreaks. Although there are significant challenges to implementation, especially for NGS, each chapter shows promise in new technologies for clinical laboratories.en_US
dc.description.tableofcontentsChapter 1 Analytical sensitivity comparison between singleplex real-time PCR and a multiplex PCR platform for detecting respiratory viruses -- Chapter 2 BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm -- Chapter 3 Application of next generation sequencing for the detection of human viral pathogens in clinical specimens -- Chapter 4 Investigation of canine parvovirus outbreak in Alaska using next generation sequencing -- General conclusion - Appendices.en_US
dc.language.isoen_USen_US
dc.subjectvirus diseasesen_US
dc.subjectdiagnosisen_US
dc.subjectAlaskaen_US
dc.subjectmethodsen_US
dc.subjectdiagnostic virologyen_US
dc.titleApplication of new technology for the diagnosis of viral infectionen_US
dc.typeThesisen_US
dc.type.degreephden_US
dc.identifier.departmentBiological Sciencesen_US
dc.contributor.chairChen, Jack
dc.contributor.committeeHueffer, Karsten
dc.contributor.committeeFerrante, Andrea
dc.contributor.committeeJilly, Bernd
refterms.dateFOA2020-03-07T01:30:43Z


Files in this item

Thumbnail
Name:
Parker_J_2019.pdf
Size:
15.15Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record